Aurora Cannabis Inc. Stock price

Equities

ACB

CA05156X8843

Pharmaceuticals

Market Closed - Toronto Stock Exchange 16:00:00 2023-12-01 EST Intraday chart for Aurora Cannabis Inc. 5-day change 1st Jan Change
0.6300 CAD +1.61% -3.08% -49.60%
Sales 2023 175 M 130 M Sales 2024 * 272 M 201 M Capitalization 295 M 218 M
Net income 2023 -199 M -147 M Net income 2024 * -48.00 M -35.53 M EV / Sales 2023
1,00x
Net cash position 2023 73.32 M 54.28 M Net cash position 2024 * 133 M 98.46 M EV / Sales 2024 *
0,59x
P/E ratio 2023
-1,13x
P/E ratio 2024 *
-4,97x
Employees 1,338
Yield 2023
-
Yield 2024 *
-
Free-Float 99.97%
More Fundamentals * Assessed data
Dynamic Chart
Toronto Stocks Inch Lower; AtkinsRealis Rises on 3Q Beat DJ
Piper Sandler On Aurora Cannabis MT
Transcript : Aurora Cannabis Inc., Q2 2024 Earnings Call, Nov 09, 2023 CI
Aurora Cannabis Up 19% After Hours as it Swings to a Profit in its Fiscal Second Quarter MT
Aurora Cannabis Inc. Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023 CI
Aurora Cannabis Inc. Provides Revenue Guidance for Third Quarter of Fiscal 2024 CI
Aurora Cannabis Brief: Re-Affirming Target of Achieving Positive Free Cash Flow in Calendar Year 2024 MT
Aurora Cannabis Brief: Net cash position of over $200 Million, Expects to Repay Remaining US$5.3 Million Balance of Convertible Senior Notes in February 2024 MT
Aurora Cannabis Brief: FY24 Q2 Net Revenue rose 30% YoY to $63.4 Million; Cites "Strong" Growth of 42% in Global Medical Cannabis MT
North American Morning Briefing : Traders Await Powell Speech DJ
Aurora Cannabis Announcing Settlement of Patent Litigation MT
Aurora Cannabis Brief: Announcing Settlement of Patent Litigation MT
Aurora Cannabis Closed its C$38.8 Million Bought Deal Financing, Including Full Exercise of Over-Allotment Option MT
Aurora Cannabis Brief: Intends to Repay Remaining Convertible Debt Balance, Saving Almost C$2 Million in Annual Interest Payments MT
Aurora Cannabis Brief: Announcing Closing of its C$38.8 Million Bought Deal Financing, Including the Full Exercise of the Over-Allotment Option MT
More news
1 day+1.61%
1 week-3.08%
Current month+1.61%
1 month-1.56%
3 months-3.08%
6 months-5.97%
Current year-49.60%
More quotes
1 week
0.60
Extreme 0.6
0.65
1 month
0.60
Extreme 0.6
0.71
Current year
0.56
Extreme 0.56
1.59
1 year
0.56
Extreme 0.56
1.99
3 years
0.56
Extreme 0.56
24.10
5 years
0.56
Extreme 0.56
164.04
10 years
0.56
Extreme 0.56
194.88
More quotes
Managers TitleAgeSince
Chief Executive Officer 51 2020
Director of Finance/CFO 60 2017
Chief Tech/Sci/R&D Officer - -
Members of the board TitleAgeSince
Chairman 66 2018
Director/Board Member 59 2016
Director/Board Member 51 2015
More insiders
Date Price Change Volume
23-12-01 0.6300 +1.61% 774,196
23-11-30 0.6200 0.00% 1,026,548
23-11-29 0.6200 0.00% 425,280
23-11-28 0.6200 -1.59% 353,326
23-11-27 0.6300 -3.08% 632,209

Delayed Quote Toronto Stock Exchange, December 01, 2023 at 04:00 pm

More quotes
Aurora Cannabis Inc. is a Canada-based medical cannabis company. The Company's principal business lines are focused on the production, distribution, and sale of cannabis related products in Canada and internationally. The Company’s segments include Canadian Cannabis, European Cannabis and Plant Propagation. The Company's adult-use brand portfolio includes Aurora Drift, San Rafael '71, Daily Special, Whistler, Being and Greybeard, as well as CBD brands, Reliva and KG7. Its medical cannabis brands include MedReleaf, CanniMed, Aurora and Whistler Medical Marijuana Co, as well as international brands, Pedanios, Bidiol and CraftPlant. Its cannabis products are primarily cultivated and manufactured in the facilities in Bradford Ontario, Pemberton, British Columbia, and Odense, Denmark. The Company is focused on offering its cannabis products to global medical cannabis market, recreational cannabis market and global hemp-derived cannabidiol (CBD) markets.
More about the company
Trading Rating :
Investor Rating :
ESG Refinitiv :
D+
More Ratings
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
10
Last Close Price
0.6300CAD
Average target price
1.062CAD
Spread / Average Target
+68.61%
Consensus
  1. Stock
  2. Equities
  3. Stock Aurora Cannabis Inc. - Toronto Stock Exchange
The best tools reserved for subscribers to boost the performance of your investments!
Optimize my profits
fermer